Orphagen Pharmaceuticals, Inc.
San Diego, CA Doing business as Orphagen Pharmaceuticals
- UEI
- GNYKMU6R4H64
- CAGE
- 44GQ5
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2727 Morava Pl, San Diego, CA 92110, USA
- Website
- orphagen.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A novel, pleiotropic oral drug class that inhibits GUT migration of activated t cells - abstract inflammatory bowel… | National Institute of Diabetes and Digestive and Kidney Diseases | $1,712,226 | |
| Preclinical development of or-449, a novel targeted therapy for adrenocortical cancer - abstract adrenocortical… | National Cancer Institute | $5,304,873 | |
| Translational feasibility of an oral, non-hormonal, male contraceptive pill | National Institute of Child Health and Human Development | $1,812,843 | |
| HLS-small molecule discovery at novel target for fetal hemoglobin induction | National Institutes of Health | $325,051 | |
| Orphan nuclear receptor as novel drug discovery target for cancer immunotherapy | National Institutes of Health | $224,954 |
Quick answers
What is Orphagen Pharmaceuticals, Inc.'s UEI?
Orphagen Pharmaceuticals, Inc.'s Unique Entity ID (UEI) in SAM.gov is GNYKMU6R4H64.
What is Orphagen Pharmaceuticals, Inc.'s CAGE code?
Orphagen Pharmaceuticals, Inc.'s CAGE code is 44GQ5.
Where is Orphagen Pharmaceuticals, Inc. located?
Orphagen Pharmaceuticals, Inc.'s physical address in SAM.gov is 2727 Morava Pl, San Diego, CA 92110, USA.
Is Orphagen Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Orphagen Pharmaceuticals, Inc.'s SAM.gov registration is active through October 21, 2026.
What is Orphagen Pharmaceuticals, Inc.'s most recent federal award?
Orphagen Pharmaceuticals, Inc.'s most recent federal grant award is A novel, pleiotropic oral drug class that inhibits GUT migration of activated t cells - abstract inflammatory bowel… (R44DK136458), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 15, 2024.
On GovTribe
See Orphagen Pharmaceuticals, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors